Commitments and Contingencies (Details) - USD ($) |
3 Months Ended | |
|---|---|---|
Apr. 24, 2025 |
Mar. 31, 2025 |
|
| Commitments and Contingencies [Line Items] | ||
| Option date of initial public offering days | 45 days | |
| Underwriter cash discount (in Dollars per share) | $ 0.2 | |
| Aggregate initial public offering (in Dollars) | $ 4,500,000 | |
| Deferred fee per share (in Dollars per share) | $ 0.4 | |
| Aggregate amount (in Dollars) | $ 9,000,000 | |
| Over-Allotment Option [Member] | ||
| Commitments and Contingencies [Line Items] | ||
| Additional units | 3,000,000 | |
| Subsequent Event [Member] | ||
| Commitments and Contingencies [Line Items] | ||
| Stock options exercised | 2,500,000 | |
| Unit of remaining exercise option | 500,000 | |
| Subsequent Event [Member] | Over-Allotment Option [Member] | ||
| Commitments and Contingencies [Line Items] | ||
| Additional units | 2,500,000 |
| X | ||||||||||
- Definition Amount of aggregate closing initial public offering. No definition available.
|
| X | ||||||||||
- Definition Number of deferred fee per share. No definition available.
|
| X | ||||||||||
- Definition The option date of initial public offering days. No definition available.
|
| X | ||||||||||
- Definition Underwriter cash discount. No definition available.
|
| X | ||||||||||
- Definition Unit of remaining exercise option. No definition available.
|
| X | ||||||||||
- Definition Units issued during period shares new issues. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|